Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-09-05
2006-09-05
Huff, Sheela J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S324000, C530S387700, C530S387900, C530S388100, C435S810000, C435S325000, C435S326000, C435S331000, C435S344100, C435S330000
Reexamination Certificate
active
07101979
ABSTRACT:
Antibody to endostatin protein that is an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression, that is approximately 18 kDa as determined by non-reduced gel electrophoresis, and approximately 20 kDa as determined by reduced gel electrophoresis and corresponds to a C-terminal fragment of collagen type XVIII, and methods of detecting and treating angiogenesis-related disease therewith.
REFERENCES:
patent: 5643783 (1997-07-01), Olsen et al.
patent: 6080728 (2000-06-01), Mixson
patent: 58036391 (1983-03-01), None
patent: WO 91/10424 (1991-07-01), None
patent: WO 93/16716 (1993-09-01), None
patent: WO 95/25543 (1995-09-01), None
patent: WO 95/29242 (1995-11-01), None
Author: Title: Chapter 12: Vectors for Gene Therapy Publ:Current Protocols in Human GeneticsVol/Iss: Pages: Date: 1997.
Author: Abe, N. et al. Title: Identification of a Novel Collagen Chain Represented by Extensive Interruptions in the Triple-Helical Region Publ:Biochemical and Biophysical Research Communicationsvol./Iss: 196 (2) pp.: 576-582 Date: Oct. 29, 1993.
Author: Algire, G.H. et al. Title: Vascular reactions of normal and milignant tumors in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants Publ:Journal of the National Cancer Institutevol./Iss: 6 pp.: 73-85 Date: Aug. 1945.
Author: Angiolillo, A. et al. Title: Human Interferon-inducible Protein 10 is a Protent Inhibitor of Angiogenesis in Vivo. Publ:The Journal of Experimental Medicinevol./Iss: 182 pp.: 155-162 Date: Jul. 1995.
Author: Boussif, O. et al. Title: A versatile vector for gene and oligonuclotide transfer into cells in culture and in vivo Publ:Proc. Natl. Acad. Sci. USAvol./Iss: 92 pp.: 7297-7301 Date:Aug. 1995.
Author: Brem, H. et al. Title: Interstitial chemotherapy with drug polymer inplmants for the treatment of recurrent gliomas. Publ:Journal of Neurosurgeryvol./Iss: 74 pp.: 441-446 Date: Mar. 1, 1991.
Author: Brockway, W. J. et al. Title: Measurement of the Binding of Antifibrinolytic Amino Acids to Various Plasminogens Publ:Archives of Biochemistry and Biophysicsvol./Iss: 151 pp.: 194-199 Date: Apr. 18, 1972.
Author: Browne Title: Expression of Recombinant Human Plasminogen and Aglycoplasmingoen in HeLa cells Publ:Fibinolysisvol./Iss: 5 pp.: 257-260 Date: Apr. 13, 1991.
Author: Calos, Michael P. Title: The potential of extrachromosomal replicating vectors for gene therapy Publ:TIGvol./Iss: 12 (11) pp.: 463-466 Date: Nov. 1996.
Author: Campbell, Alisa M. Title: General Properties and applications of monoclonal antibodies Publ:Monoclonal Antibody TechnologyVol/Iss: pp.: 1-30 Date: 1984.
Author: Cao, Y. et al. Title: gro-B, a-C-X-C- Chemokine, is an Anglogenesis inhibitor that Suppresses the Growth of Lewis Lung Carninoma in Mice Publ:Journal of Experimental Medicinevol./Iss: 182 pp.: 2069-2077 Date: Dec. 1, 1995
Author: Chen, C. et al. Title:A Strategy to Discover Circulating Angiogensis Inhibitors Generated by Human Tumors Publ:Cancer Researchvol./Iss: 55 pp.: 4230-4233 Date: Oct. 1, 1995.
Author: Chen, P. et al. Title: Genetic Mechanisms of Tumor Suppression by the Human p53 Gene Publ:Sciencevol./Iss: 250 pp.: 1576-1579 Date: Dec. 1990.
Author: Cheng, Pi-Wan Title: Receptor Ligand-Facilitated Gene Transfer: Enhancement of Liposome-Mediated Gene Transfer and Expression by Transferrin Publ:Human Gene Therapyvol./Iss: 7 pp.: 7 Date: Feb. 10, 1996.
Author: Clapp, C. et al. Title: The 16-kilodation N-terminal Fragment Of Human Prolactin Is A Protent Inhibitor Of Angiogenesis Publ:Endocrinologyvol./Iss: 133 pp.: 1292-1299 Date: Mar. 1, 1993.
Author: Cleary, S. et al. Title: Purification and Characterization of Tissue Plasminogen Activator Kringle-3Domain Expressed inEsherica coliPubl:Biochemistryvol./Iss: 28 pp.: 1884-1891 Date: 1989.
Author: Dameron, K.M. et al. Title: Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1 Publ:Sciencevol./Iss: 265 pp.: 1582-1584 Date: Sep. 9, 1994.
Author: Dardik, R. et al Title: The structure of enothelial cell thrombospondin—Characterization of the heparin-binding domains Publ:Eur J Biochemvol./Iss: 168 (2) pp.: 347-355 Date: Oct. 15, 1987.
Author: Debs, R.J. et al. Title: Regulation of Gene Expression in Vivo by Liposome-mediated Delivery of a Purified Transcription Factor Publ:The Journal of Biological Chemistryvol./Iss: 265 (18) pp.: 10189-10192 Date: Jun. 25, 1990.
Author: Dixit, V.M. et al. Title: A monoclonal antibody against human thrombospondin inhibits platelet aggregation Publ:Proc. Natl. Acad. Sci. USAvol./Iss: 82 pp.: 3472-3476 Date: May 1985.
Author: Fan et al. Title: Controlling the vasculature: angiogensis, anti-angiogensis and vascular targeting of gene therapy Publ:Trends in Pharmacolgical Sciencesvol./Iss: 16 pp.: 57-66 Date: Feb. 1995.
Author: Fidler et al. Title: The Implications of Angiogensis for the Biology and Therapy of Cancer Metastasis Publ:Cellvol./Iss: 79(2) pp.: 185-188 Date: Oct. 21, 1994.
Author: Folkman, J. Title: Tumor angiogensis and tissue factor Publ:Nature Medicinevol./Iss: 2 pp.: 167-168 Date: Feb. 1, 1996.
Author: Folkman, J. Title: What is the Evidence that Tumors are Angiogensis Dependent? Publ:Journal of the National Cancer Institutevol./Iss: 82 pp.: 4-6 Date:Jan. 3, 1990.
Author: Folkman, J. Title: Angiogenesis in cancer, vascular, rheumatoid and other disease Publ:Nature Medicinevol./Iss: 1(1) pp.: 27-31 Date: Nov. 1, 1995.
Author: Folkman, J. Title: Angiogenesis and Its Inhibitors Publ:Important Advances in OncologyVol/Iss: pp.: 42-62 Date: 1985.
Author: Folkman, J. Title: Tumor Angiogenesis: Therapeutic Implications Publ:New England Journal of Medicinevol./Iss: 285(12) pp.: 1182-1186 Date: Nov. 18, 1971.
Author: Folkman, J. et al. Title: Long-term culture of capillary endothelial cells Publ:Proceedings of the National Academy of Science USAvol./Iss: 76 pp.: 5217-5221 Date: Oct. 1, 1979.
Author: Folkman, J. et al Title: Induction of angiogensis during the transition from hyperplasia to neoplasia Publ:Naturevol./Iss: 339 pp.: 58-61 Date: May 4, 1989.
Author: Folkman, J. et al. Title: Tumor Behavior In Isolated Perfused Oragans in vitro Growth and Metastases of Biopsy Materials in Rabbit Thyroid and Canine Intestinal Segment Publ:Annals of Surgeryvol./Iss: 164(3) pp.: 491-502 Date: Sep. 1, 1966.
Author: Fujiwara T. et al. Title: Induction of Chemosensitivity in Human Lung Cancer Cells in Vivo by Adenovirus-mediated Transfer of the Wild-Typep53Gene Publ:Cancer Researchvol./Iss: 54 pp.: 2287-2291 Date: May 1, 1994.
Author: Gavrieli, Y. et al. Title: Identification of Programmed Cell Death in Situ via Specific Labelling of Nuclear DNA Fragmentation Publ:Journal of Cell Biologyvol./Iss: 119 pp.: 493-501 Date: 1992.
Author: Gimbrone, M.A. et al. Title: Tumor growth and neovascularization: An experimental model using the rabbit comea Publ:Journal of the National Cancer Institutevol./Iss: 52(2) pp.: 413-427 Date: Feb. 1974.
Author: Gimbrone, M.A. et al. Title: Tumor dormancy in vivo by Prevention of Neovascularization Publ:Journal of Experimental Medicinevol./Iss: 136 pp.: 261-276 Date: 1972.
Author: Goldman, C.K. et al. Title: In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer Publ:Nature Brochurevol./Iss: 15 pp.: 462-466 Date: May 1997.
Author: Good, DJ. et al. Title: A tumor suppressor-dependent inhibitor of angiogensis is immunologically and functionally indistinguishable from a fragment of therbospondin Publ:Proceedings of the National Academy of Science USAvol./Iss: 87 pp.: 6624-6628 Date: Sep. 1990.
Author: Grant, D.S. et al. Title: Scatter factor induces blood vessel formation in vivo Publ:Proceedings of the National Academy of Science USAvol./Iss: 99 pp.: 1937-1941 Date: Mar. 1993.
Author: Grant, D.S. et al. Title: Two Different Laminin Domains Mediate the Differentiation of Human Endothelial Cells into Capillary-like Structures in Vitro Publ:Cellvol./Iss: 58 pp.: 933-943 Date: Sep. 8, 1989.
Author: Gross, J.L. et al. Title: Modulation of Solid Tumor Growth in vivo by bFGF (Abstract only) Publ:Proceedings of t
Boehm Thomas
Folkman M. Judah
O'Reilly Michael S.
Huff Sheela J.
Kilpatrick & Stockton LLP
The Children's Medical Center Corporation
LandOfFree
Antibodies to antiangiogenic compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to antiangiogenic compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to antiangiogenic compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3607747